FutureFuel posted Q2 2025 revenue of $35.673M, down 51% YoY, due to challenging biodiesel market conditions and high feedstock prices. The company recorded a net loss of $10.416M, an operating loss of $11.928M, and negative adjusted EBITDA of $9.823M. Chemical segment revenue was $16.619M, while biofuel revenue fell sharply to $19.054M. Capital expenditures rose to $9.478M for the quarter.
Total revenue declined 51% YoY to $35.673M, driven by a 64% drop in biofuel revenue.
Net loss was $10.416M compared to net income of $9.571M a year earlier.
Adjusted EBITDA was negative $9.823M versus positive $6.907M in Q2 2024.
Capital expenditures increased to $9.478M, mainly for a new custom chemical plant.
FutureFuel plans to restart biodiesel production once feedstock prices normalize, potentially in late 2025 or early 2026, while continuing to expand its chemical business and commission its new custom chemical plant in Q3 2025.
Visualization of income flow from segment revenue to net income